Dahlia Putrus, PA-C Dahlia, PA-C is a board-certified Physician Assistant specializing in aesthetic medicine, bringing both emergency medicine precision and an artists eye to every treatment
Allison Whitten AstraZeneca reports mixed Phase 3 results across oncology and rare disease AstraZeneca reported mixed late-stage clinical results, with its Claudin 18.2-targeting antibody-drug conjugate sonesitatug vedotin meeting its primary endpoint in patients with previously treated advanced gastric cancer, while rare disease therapy Ultomiris missed the primary endpoint in a Phase 3 trial for thrombotic microangiopathy following haematopoietic stem cell transplantation (HSCT-TMA)
Protein expression of alpha-SMA was assessed by Western blot [29,30,31]
TB500, a potent synthetic analog of thymosin beta-4, increases cell migration, angiogenesis, and collagen deposition, supporting muscle recovery and flexibility
Rodent models show accelerated tendon healing, increased collagen organisation, and improved biomechanical strength under controlled injury conditions